Replies to post #19976 on Intellect Neurosciences Inc. (fka ILNS)

[john1045]

Was this GSK trial done with ILNS Conjumab AMD program?

GSK completed GSK933776 (anti Aß peptide, n-terminus ) AMD phase 2 trial last month.
Enrolment: 190

https://clinicaltrials.gov/ct2/show/NCT01342926?term=gsk933776&rank=4